Concepts (68)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Palsy | 9 | 2022 | 62 | 3.550 |
Why?
|
| Muscle Spasticity | 4 | 2021 | 24 | 0.940 |
Why?
|
| Neuromuscular Agents | 2 | 2021 | 29 | 0.880 |
Why?
|
| Epilepsies, Partial | 1 | 2022 | 9 | 0.860 |
Why?
|
| Epilepsy, Generalized | 1 | 2022 | 4 | 0.860 |
Why?
|
| Child | 10 | 2022 | 2442 | 0.860 |
Why?
|
| Chloral Hydrate | 1 | 2022 | 2 | 0.830 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 9 | 0.830 |
Why?
|
| Drug Labeling | 1 | 2018 | 3 | 0.620 |
Why?
|
| Muscle Relaxants, Central | 2 | 2007 | 6 | 0.560 |
Why?
|
| Baclofen | 2 | 2007 | 12 | 0.560 |
Why?
|
| Anticonvulsants | 2 | 2022 | 65 | 0.410 |
Why?
|
| Humans | 14 | 2022 | 32114 | 0.390 |
Why?
|
| Hemiplegia | 2 | 2011 | 13 | 0.340 |
Why?
|
| Phenol | 1 | 2008 | 6 | 0.320 |
Why?
|
| Quadriplegia | 1 | 2008 | 11 | 0.320 |
Why?
|
| Botulinum Toxins | 1 | 2008 | 38 | 0.310 |
Why?
|
| Paraparesis, Spastic | 1 | 2006 | 1 | 0.280 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2006 | 16 | 0.270 |
Why?
|
| Treatment Outcome | 3 | 2021 | 3306 | 0.240 |
Why?
|
| Conscious Sedation | 1 | 2022 | 24 | 0.210 |
Why?
|
| Seizures | 1 | 2022 | 64 | 0.210 |
Why?
|
| Hypnotics and Sedatives | 1 | 2022 | 28 | 0.210 |
Why?
|
| Electroencephalography | 1 | 2022 | 73 | 0.200 |
Why?
|
| Administration, Oral | 1 | 2022 | 187 | 0.200 |
Why?
|
| Nonverbal Communication | 1 | 2020 | 4 | 0.190 |
Why?
|
| Infant | 2 | 2022 | 1062 | 0.180 |
Why?
|
| Lower Extremity | 1 | 2021 | 100 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2021 | 510 | 0.160 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 43 | 0.150 |
Why?
|
| Injections, Spinal | 2 | 2007 | 108 | 0.140 |
Why?
|
| Adult | 2 | 2022 | 9380 | 0.110 |
Why?
|
| Review Literature as Topic | 1 | 2012 | 8 | 0.100 |
Why?
|
| Observer Variation | 1 | 2012 | 105 | 0.100 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2011 | 6 | 0.100 |
Why?
|
| Efferent Pathways | 1 | 2011 | 8 | 0.100 |
Why?
|
| Motor Cortex | 1 | 2011 | 12 | 0.100 |
Why?
|
| Child Development | 1 | 2012 | 43 | 0.100 |
Why?
|
| Brain Mapping | 1 | 2011 | 178 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2011 | 240 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 765 | 0.090 |
Why?
|
| Anti-Dyskinesia Agents | 1 | 2008 | 5 | 0.080 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2008 | 15 | 0.080 |
Why?
|
| Musculoskeletal Diseases | 1 | 2008 | 37 | 0.080 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2007 | 8 | 0.070 |
Why?
|
| Infusions, Parenteral | 1 | 2007 | 65 | 0.070 |
Why?
|
| Chronic Disease | 1 | 2008 | 406 | 0.070 |
Why?
|
| Age Factors | 1 | 2008 | 1189 | 0.060 |
Why?
|
| Female | 4 | 2011 | 20015 | 0.050 |
Why?
|
| Adolescent | 2 | 2011 | 3568 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2008 | 3510 | 0.040 |
Why?
|
| Male | 3 | 2011 | 19217 | 0.040 |
Why?
|
| Child Behavior | 1 | 2012 | 27 | 0.030 |
Why?
|
| Evoked Potentials, Motor | 1 | 2011 | 8 | 0.030 |
Why?
|
| Ankle | 1 | 2011 | 29 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 56 | 0.020 |
Why?
|
| Hand | 1 | 2011 | 66 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2012 | 164 | 0.020 |
Why?
|
| Fasciitis, Plantar | 1 | 2008 | 2 | 0.020 |
Why?
|
| Clubfoot | 1 | 2008 | 3 | 0.020 |
Why?
|
| Contracture | 1 | 2008 | 16 | 0.020 |
Why?
|
| Exocytosis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Injections, Intralesional | 1 | 2008 | 15 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 2008 | 26 | 0.020 |
Why?
|
| Tennis Elbow | 1 | 2008 | 18 | 0.020 |
Why?
|
| Arthroplasty, Replacement | 1 | 2008 | 17 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 1270 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2008 | 780 | 0.010 |
Why?
|